Oncology Insights derived from a series of proprietary TRM sponsored events
Invitation-only expert panels provide insights from the oncology and hematology marketplace
Commercial and medical teams thrive on knowledge and expertise from clinical thought leaders. Our proprietary events facilitate the exchange of knowledge from expert physicians to other clinical and market stakeholders. Our in-depth clinical, scientific, and market reports are derived from closed-door knowledge-sharing events, fully sponsored by TRM Oncology, without outside funding.
Insights reports from these events are available for purchase and provide a look into the current landscape of various tumor types from the perspective of both oncology experts and community oncologists. Reports help our life science partners understand how emerging research will affect therapeutic decision-making, ongoing clinical trials, the development of new compounds, and future treatment paradigms.
We believe the right expertise leads to the right outcomes. That’s why TRM Oncology coordinates various data-collection events with key opinion leaders and community oncologists, to best understand how treatment decisions are made. These tailored, innovative, and creative programs identify and continuously engage key stakeholders via a multitude of platforms and channels.
With creative strategies to convey scientific insights,
we can deliver your brand to the world.
Oncology Insights Services
State-of-the-art strategic reports derived from closed-door expert roundtables
EPIC Conference Coverage Report
Provides an immediate understanding of newly presented data via closed door expert roundtables
Provides insights into regionally specific treatment patterns from community oncologists
On-demand market research from practicing community physicians
Strategic report designed to quickly measure and reveal practice patterns
OncoBoard Online Communities
Collaborative tool to create, send, and manage insight questions with experts
Real-world examples of how our strategic services lead to high-impact successes
Read more about Oncology Insights